2016 ngs health_lecture

65
GENOMICS IN MEDICINE The Future of Healthcare

Upload: dan-gaston

Post on 16-Apr-2017

329 views

Category:

Science


0 download

TRANSCRIPT

Page 1: 2016 ngs health_lecture

GENOMICS IN MEDICINEThe Future of Healthcare

Page 2: 2016 ngs health_lecture

Goal of Genomic Medicine

• Identify genetic variation that causes or contributes to disease (diagnostic)• Inform treatment options or patient care (therapeutic/prognostic)• Provides other (potentially) useful clinical information

Page 3: 2016 ngs health_lecture

Innovation Cycle in Healthcare

Application

Research

Innovation

Page 4: 2016 ngs health_lecture

Human Genome Project 1st Draft

Page 5: 2016 ngs health_lecture

Personalized Medicine: Expectations and Reality

Page 6: 2016 ngs health_lecture

Primary Clinical Applications• Severe childhood genetic disorders• Clinical Exome or Targeted Disease Panel• Cheaper than 4 or 5 sequential gene tests• Reduced diagnostic odyssey

• Cancer• Classification• Treatment Guidance• Targeted Panels

• Infectious disease• Epidemiology/Outbreak monitoring• Strain discrimination

Page 7: 2016 ngs health_lecture

What Drives Genomic Innovation in Medicine?

Cost

Knowledge Utility

Page 8: 2016 ngs health_lecture

What Drives Genomic Innovation in Medicine?

Cost

Knowledge Utility

Page 9: 2016 ngs health_lecture
Page 10: 2016 ngs health_lecture
Page 11: 2016 ngs health_lecture
Page 12: 2016 ngs health_lecture

The Players

Page 13: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Glass Plate (Flowcell)

Adapter Primers

Page 14: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Genomic DNA Fragment

Adapter Sequence

Page 15: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Page 16: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Bridge Amplification

Nucleotides

Enzyme to initiate Bridge Amplification

Page 17: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Page 18: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Cluster Generation

Page 19: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

dNTPs

Page 20: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

dNTPs

Page 21: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Page 22: 2016 ngs health_lecture

Illumina Sequencing-By-Synthesis

Page 23: 2016 ngs health_lecture

What We Get

Reference Human Genome

Millions of 'Short Read' Sequences:

Typically 75 – 300 bp in size

Page 24: 2016 ngs health_lecture

What We Need To Do

Reference Human Genome

Millions of 'Short Read' Sequences:

Typically 75 – 300 bp in size

Page 25: 2016 ngs health_lecture

What We Need To Do

Reference Human Genome

Millions of 'Short Read' Sequences:

Typically 75 – 300 bp in size

Page 26: 2016 ngs health_lecture

How We Do It• Fast Computers with lots of memory• Fancy Math

Page 27: 2016 ngs health_lecture

How We Do It• Fast Computers with lots of memory• Fancy Math

Some details later

Page 28: 2016 ngs health_lecture

What Drives Genomic Innovation in Medicine?

Cost

Knowledge Utility

Page 29: 2016 ngs health_lecture

Composition of the Human Genome

Page 30: 2016 ngs health_lecture

Exome Sequencing – Baited Capture

Page 31: 2016 ngs health_lecture

Amplicon Sequencing

Page 32: 2016 ngs health_lecture

Targeted Sequencing Panels

Page 33: 2016 ngs health_lecture

Bioinformatics Roles•Support/Maintain Computational Infrastructure•Process Data and Generate Reports•Quality Control•Report to Stake Holders (Clinicians, Fellow Scientists)

Page 34: 2016 ngs health_lecture

Typical Bioinformatics WorkflowQC of Raw

Data

Map to Reference

QC

Find Variants

QC

Annotate

Filter

Page 35: 2016 ngs health_lecture

It Sounds simple but…• For every stage there are multiple programs available and published in the literature

Page 36: 2016 ngs health_lecture

It Sounds simple but…• For every stage there are multiple programs available and published in the literature• For every program there are a wide-variety of parameter values and options. Defaults often “good enough” but not always

Page 37: 2016 ngs health_lecture

It Sounds simple but…• For every stage there are multiple programs available and published in the literature• For every program there are a wide-variety of parameter values and options. Defaults often “good enough” but not always•Best combinations of programs and options not well understood

Page 38: 2016 ngs health_lecture

It Sounds simple but…• For every stage there are multiple programs available and published in the literature• For every program there are a wide-variety of parameter values and options. Defaults often “good enough” but not always•Best combinations of programs and options not well understood• Protocols changing rapidly as new technologies and methods developed

Page 39: 2016 ngs health_lecture

Clinical BioinformaticsValidate, validate, validate!

Page 40: 2016 ngs health_lecture

Typical Bioinformatics WorkflowQC of Raw

Data

Map to Reference

QC

Find Variants

QC

Annotate

Filter

Page 41: 2016 ngs health_lecture

Clinical Genomics: Identify Clinically Relevant Genetic Variation

Page 42: 2016 ngs health_lecture

Discovering Disease-Causing Genetic Variants

4 million genetic variants

2 million associated with protein-coding

genes10,000

possibly of disease

causing type

1500 <1% frequency in population

Clinically Relevant Genetic Variants

Page 43: 2016 ngs health_lecture

If a problem cannot be solved, enlarge it.

--Dwight D. Eisenhower

Supreme Commander Allied Forces: Second World War34th President of the USA

4 million genetic variants

2 million associated with protein-coding

genes10,000

possibly of disease

causing type

1500 <1% frequency in population

Page 44: 2016 ngs health_lecture

Knowledge Required

Variant

Gene

Population

Frequency

Pathways

Functions

Tissues

Variant Type

Impact on

Protein

Page 45: 2016 ngs health_lecture

Populations are Important

Page 46: 2016 ngs health_lecture

2001 – Present: 15 years of Knowledge Building

Exome Variant Server

Exome Aggregation Consortium

Page 47: 2016 ngs health_lecture

2001 – Present: 15 years of Knowledge Building

Page 48: 2016 ngs health_lecture

2001 – Present: 15 years of Knowledge Building

Page 49: 2016 ngs health_lecture

Potential Pitfalls with Annotation Sources

•Databases often overlap and agree, but there may be disagreements• Source of information: Predicted versus experimental• Incorrect and out-of-date information• Large-scale un-validated versus manually curated datasets

Page 50: 2016 ngs health_lecture

Building Knowledge Take-Away•Clinical utility relies on:

•Knowledge of background variation from well sampled populations•Knowledge of function of as much genomic sequence as possible•Well defined workflows•Knowledge of sources of error

Page 51: 2016 ngs health_lecture

Variant Annotation Pipeline ExampleCalled

Genomic

Variants

Annotation PipelineAnnotat

ed Genomic Variants

1000 Genome

s

Exome Variant Server

ExAcExomes

UK10KGenome

s

Etc...

Ensembl

UCSC

NCBI

Gencode

SIFT

PolyPhen

CADD OMIM

COSMIC

HGMD

Locus and

Disease Specific Databas

esDrug DBs

Page 52: 2016 ngs health_lecture

Genetic Variant Reporting

Page 53: 2016 ngs health_lecture

Genetic Variant Reporting

4 million genetic variants

2 million associated with protein-coding

genes10,000

possibly of disease

causing type

1500 <1% frequency in population

Clinically Relevant Genetic Variants

Page 54: 2016 ngs health_lecture

What Drives Genomic Innovation in Medicine?

Cost

Knowledge Utility

Page 55: 2016 ngs health_lecture

Genomic Medicine: In the Clinic

• Rapid diagnosis of genetic disease in NICU cases• Quicker and cheaper than sequential genetic testing (traditional method)• 50 hour diagnosis

Page 56: 2016 ngs health_lecture

Genomic Medicine: In the Clinic

Page 57: 2016 ngs health_lecture

Genomic Medicine: In the Clinic

Page 58: 2016 ngs health_lecture

Genomic Medicine: In the Clinic

Page 59: 2016 ngs health_lecture

The Missing Pieces?

Page 60: 2016 ngs health_lecture

The Missing Pieces?

Exon 1 Intron 1 Exon 2Reference

Patient

StartTAAStopmRNA coding for protein

Exon 1 Intron 1 Exon 2

TACTyrSplice Site

Loss

Missense/Frameshift Stop Gain

Page 61: 2016 ngs health_lecture

Where Are We Going?

Page 62: 2016 ngs health_lecture

Direct-to-Consumer

Page 63: 2016 ngs health_lecture

New Technologies: Oxford Nanopore

Page 64: 2016 ngs health_lecture
Page 65: 2016 ngs health_lecture

Summary of Key Points

•Clinical application possible when cost and applicable knowledge reach critical point• Personalized/Precision genomic medicine is here already• The genome alone isn’t enough• Large population surveys of healthy individuals• Sample from diverse human populations globally• Large-scale surveys of genes, genetic elements, and their functions• Data, data, and more data are required for clinical interpretation